Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer (Q85112955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Anna Rita Cervino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Zora Baretta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Lorenzo Vinante

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Michele Gregianin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Cristina Ghiotto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Giorgio Saladini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Guido Sotti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

30 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

293-301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882280%20AND%20SRC:MED&resulttype=core&format=json

[18F]fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer

14 February 2020

cites work

1 reference

12 December 2020

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial

1 reference

12 December 2020

Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET.

1 reference

12 December 2020

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

12 December 2020

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

12 December 2020

Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective

1 reference

12 December 2020

Clinical impact of [(18)F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels: a preliminary report.

1 reference

12 December 2020

F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers

1 reference

12 December 2020

The Place of Whole-Body PET FDG for the Diagnosis of Distant Recurrence of Breast Cancer

1 reference

12 December 2020

The applications of PET in clinical oncology

1 reference

12 December 2020

18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer

1 reference

12 December 2020

Routine follow up of breast cancer in primary care: randomised trial

1 reference

12 December 2020

Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.

1 reference

12 December 2020

Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience

1 reference

12 December 2020

PET/CT and breast cancer

1 reference

12 December 2020

FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer

1 reference

12 December 2020

Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma

1 reference

12 December 2020

Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.

1 reference

12 December 2020

Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET).

1 reference

12 December 2020

Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators

1 reference

12 December 2020

FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.

1 reference

12 December 2020

Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers

1 reference

12 December 2020

18F-FDG-PET/CT in patients with breast cancer and rising Ca 15-3 with negative conventional imaging: a multicentre study.

1 reference

12 December 2020

18F-fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer

1 reference

12 December 2020